News | December 15, 2010

aycan, Definiens Partner to Market Lung Tumor Detection Solution


December 15, 2010 – Definiens and aycan have formed a partnership to complete the first joint project to quantify and analyze lung tumors.

Under the partnership, Definiens has combined its LungExpert with aycan’s OsiriX PRO to create a workstation that quantifies lung tumors according to RECIST and WHO guidelines and also by their volume. This new integrated solution enables efficient analysis of lesions, including automated quantification of lung tumors.

The new workstation is expected to be available in early 2011.

For more information: www.aycan.com, www.definiens.com

Related Content

Hospital for Special Surgery Invests in Sectra Orthopedic 3-D Planning Software
News | Orthopedic Imaging | January 18, 2018
January 18, 2018 – International medical imaging IT and cybersecurity company Sectra announces that Hospital for Spec
Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
EchoPixel Showcases Next-Generation Surgical Planning With True 3-D Interactive Mixed Reality Software
News | Advanced Visualization | January 08, 2018
January 8, 2018 — EchoPixel showcased the latest version of True 3D, its interactive,...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
FDA Announces Final Guidance and Webinar for Technical Considerations for 3-D-Printed Medical Devices
News | 3-D Printing | January 03, 2018
The U.S. Food and Drug Administration (FDA) issued the final version of the guidance, “Technical Considerations for...
Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs. Dave Fornell
News | Lung Cancer | December 22, 2017
Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City...
News | Enterprise Imaging | December 21, 2017
Vital Images showcased enhancements to its enterprise imaging solutions at the Radiological Society of North America (...
Videos | Neuro Imaging | December 21, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MR
Overlay Init